Clues to tRNA Evolution from the Distribution of Class II tRNAs and Serine Codons in the Genetic Code.

Life (Basel)

Department of Biochemistry, University of Otago, Dunedin 9016, New Zealand.

Published: February 2016

We have previously proposed that tRNA(Gly) was the first tRNA and glycine was the first amino acid incorporated into the genetic code. The next two amino acids incorporated would have been the other two small hydrophilic amino acids serine and aspartic acid, which occurred through the duplication of the tRNA(Gly) sequence, followed by mutation of its anticodon by single C to U transition mutations, possibly through spontaneous deamination. Interestingly, however, tRNA(Ser) has a different structure than most other tRNAs, possessing a long variable arm; because of this tRNA(Ser) is classified as a class II tRNA. Also, serine codons are found not only in the bottom right-hand corner of the genetic code table next to those for glycine and aspartic acid, but also in the top row of the table, next to those for two of the most hydrophobic amino acids, leucine and phenylalanine. In the following, I propose that the class II tRNA structure of tRNA(Ser) and the arrangement of serine codons in the genetic code provide clues to the early evolution of tRNA and the genetic code. In addition, I address Di Giulio's recent criticism of our proposal that tRNA(Gly) was the first tRNA, and discuss how early peptides produced from a restricted amino acid alphabet of glycine, serine and aspartic acid might have possessed proteolytic activity, which is possibly important for the early recycling of amino acid monomers.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810241PMC
http://dx.doi.org/10.3390/life6010010DOI Listing

Publication Analysis

Top Keywords

genetic code
20
serine codons
12
amino acid
12
amino acids
12
aspartic acid
12
codons genetic
8
trnagly trna
8
serine aspartic
8
class trna
8
amino
6

Similar Publications

Background: Patients with high-grade serous ovarian carcinoma (HGSOC) often have a personal and/or family history of breast cancers. However, the clinical association and underlying molecular interaction between breast cancer and HGSOC is not well understood. In this study, the clinical characteristics and outcomes of HGSOC patients with or without breast cancer were compared.

View Article and Find Full Text PDF

Analysis of synonymous codon usage bias in the chloroplast genome of five Caragana.

BMC Plant Biol

March 2025

College of Eco-Environmental Engineering, Qinghai University, Xining, 810016, China.

Background: The genus Caragana, known for its adaptability and high forage value, is commonly planted to rehabilitate barren land and prevent desertification. Several Caragana species are also used for medicinal purposes. Analysis of synonymous codon usage bias and their primary influencing factors in chloroplast genomes aims to provide insights into molecular research and germplasm innovation for Caragana plants.

View Article and Find Full Text PDF

Background: The IL-33/ST2 pathway plays a crucial role in the development of essential hypertension (EH). This study aimed to investigate the relationship between EH and genetic variations in this pathway in the Chinese Han population.

Methods: A total of 1,151 EH patients and 1,135 healthy controls were included in the study.

View Article and Find Full Text PDF

During bacterial translation initiation, the 30S ribosomal subunit, initiation factors, and initiator tRNA define the reading frame of the mRNA. This process is inhibited by kasugamycin, edeine and GE81112, however, their mechanisms of action have not been fully elucidated. Here we present cryo-electron microscopy structures of 30S initiation intermediate complexes formed in the presence of kasugamycin, edeine and GE81112 at resolutions of 2.

View Article and Find Full Text PDF

Characterisation of the Novel HLA-A*02:1178 Allele Using Next-Generation Sequencing Methods.

HLA

March 2025

Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China.

The HLA-A*02:1178 allele differs from HLA-A*02:07:01:01 by one nucleotide substitution in codon 326 in exon 7.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!